Carlos L. Arteaga, M.D., was appointed Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center in Dallas in September 2017.
Arteaga earned his medical degree from the Universidad de Guayaquil in Ecuador in 1980, where his father was the dean of medicine.
He has demonstrated the utility of targeting TGF-β, which causes cancer to spread, metastasize, and become resistant to chemotherapeutic drugs.
[4] Among his current research areas is triple-negative breast cancer, for which there are no targeted therapy options.
[5] He is a principal investigator for the Stand Up To Cancer (SU2C) "Targeting the PI3K Pathway in Women's Cancers" Dream Team, which provides $15 million is research funding for a research team spread across 7 institutions.